PHAC acknowledges that the advice and recommendations set out in this statement are based upon the best current available scientific knowledge and is disseminating this document for information purposes. People administering the vaccine should also be aware of the contents of the relevant product monograph s. Recommendations for use and other information set out herein may differ from that set out in the product monograph s of the Canadian manufacturer s of the vaccine s. Manufacturer s have sought approval of the vaccine s and provided evidence as to its safety and efficacy only when it is used in accordance with the product monographs.
Background: Since the introduction of HPV vaccines, several studies have been conducted in different countries to assess HPV knowledge and vaccine acceptance. The aim of this study was to perform a systematic literature review to summarize results and identify factors associated with HPV knowledge and vaccine acceptance in adolescents and their parents and to compile the measurement tools used in the published research studies performed in European countries where HPV is licensed. Methods: A systematic literature review was conducted for studies published between January 1st and December 31st Results: Seventy non-interventional studies performed in 16 European countries met the inclusion criteria. Further, Insufficient information and safety concerns were the main barriers to vaccination acceptance.
Background: In the literature conflicting opinions are detectable on the onset of adverse events as autoimmune disease post HPV vaccine and often case reports describes the onset of one of these events, but don't emerge a clear relationship and we don't have data to support it. Methods: We carried out a systematic review to identify all scientific publications dealing with the correlation between vaccine anti-papillomavirus and new onset of autoimmune diseases. We searched the main scientific databases PubMed, Sciverse Scopus, Web of knowledge and Cochrane Central Register of Controlled Clinical Trials for the following search terms: "vaccine"; "anti-papillomavirus"; "autoimmune"; "disease"; "disorder".
These vaccines are designed to protect an individual against an initialinfection; thus the vaccines are given pre-exposure. A synthetic virus that is similar in structure and characteristics to anatural virus except that it lacks the capacity to replicate. Commonly called the cabbage looper, a pest of plants such ascabbage, broccoli, cauliflower, Chinese cabbage.